Viewing nowCombinationBalsafos Tablet 5/160 mg (Amlodipine Besylate, Valsartan)
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.

MFDS item code 201308468 · Approved 2013.07.30 · Insurance code 644913600
Treatment of essential hypertension not controlled with monotherapy
For patients with essential hypertension, blood pressure may not be sufficiently controlled with either amlodipine or valsartan alone. In such cases, using both medications together may lower blood pressure more effectively. Amlodipine dilates blood vessels to reduce blood pressure, while valsartan helps control blood pressure by inhibiting blood vessel constriction. The combination therapy of these two medications is effective in improving blood pressure control and reducing the risk of cardiovascular diseases. Therefore, the combined treatment of amlodipine and valsartan is used for the appropriate management of essential hypertension.
The recommended dose of Valsaforce Tablets is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍValsaforce Tablets 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍValsaforce Tablets 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍValsaforce Tablets 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with Valsaforce Tablets 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients undergoing dialysis, as there is no experience with its use in these patients. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should preferably not exceed 80mg. If a dose of 80mg or more per day is administered, consider whether the benefits of treatment outweigh the risks when increasing the dose. This medicine should not be administered to patients with severe hepatic impairment, cirrhosis, or biliary obstruction. Elderly patients aged 65 years and older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not take this medication if you are allergic to any of its active ingredients or similar medications, if you are pregnant or breastfeeding, or if you have severe kidney or liver diseases, or a history of specific heart diseases or angioedema. Patients with low sodium or fluid levels may experience hypotension; therefore, it is essential to manage such conditions before taking this medication and to monitor blood pressure and condition carefully during treatment. This medication can increase blood potassium levels, so if taken with potassium supplements or potassium-sparing diuretics, potassium levels should be checked frequently. Patients with renal impairment or kidney transplant recipients should use caution as this medication may affect renal function. If symptoms of angioedema occur, discontinue use immediately and do not resume. Patients with heart failure or post-myocardial infarction should carefully monitor renal function and blood pressure while on this medication, and patients with acute myocardial infarction should also be cautious. Dose adjustments may be necessary for individuals with impaired liver function, and this medication should not be used in severe liver disease cases. Dizziness or fatigue may occur during treatment, so caution is advised when driving or operating machinery. When combining this medication with other antihypertensive medications or specific drugs, interactions may occur; therefore, consultation with a doctor or pharmacist is necessary, especially for frequent checks of potassium levels, renal function, and blood pressure. This medication is not recommended for children under 18 years of age. Overdose may lead to severe hypotension or cardiac issues, so care should be taken to not exceed the prescribed dosage. If pregnant or planning to become pregnant, consultation with a doctor is essential before taking this medicine, and breastfeeding women should also avoid this treatment.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, polydipsia, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, serum sickness including hypersensitivity, increased serum potassium, vasculitis, increased liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory loss, dysgeusia, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurogenic hypersensitivity, Stevens-Johnson syndrome, itching, peripheral edema, hypotension
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, avoid storing it in excessively hot or cold places; storing it at room temperature between 1 degree and 30 degrees Celsius is safe.
Dark yellow oblong film-coated tablet
28 tablets (14 tablets/PTP packaging × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.